
Barberry and Amla Form the Basis of the Blend
Novaberin™ combines barberry (Berberis aristata), a botanical source of berberine, with amla fruit (Phyllanthus emblica), also known as Indian gooseberry. Givaudan lists finished-blend specifications of more than 4% berberine and more than 3% gallic acid. These figures describe the content of two measured compounds in the powder. For supplement developers comparing botanical ingredients, the specifications provide a basis for reviewing the blend's composition alongside its species identity and physical form. They also give quality teams two defined values to check when evaluating ingredient documentation.
Six-Month Study Compared the Blend With Placebo
Givaudan's launch announcement summarized a 180-day study in which 17 adults received 250 mg of Novaberin™ twice daily and 16 received placebo. The company reported statistically significant differences versus placebo for the outcomes highlighted in its release, which covered weight management, blood glucose, and lipid measures. The announcement cited company-held data and indicated that full publication was pending. The results therefore represent an early report from a small study. A full publication would allow readers to examine the size and variability of the reported changes, as well as the methods used to measure them.


Indian Sourcing Comes With Botanical Identity Documentation
Givaudan says it sources both botanicals in India and provides identity and traceability documentation for Novaberin™. The company presents that documentation as part of its approach to verifying botanical authenticity and addressing adulteration concerns in ingredient supply chains. In procurement, identity records establish which species were sourced, while traceability records help connect incoming materials to their origins. The two marker specifications serve a different purpose by describing the composition of the finished blend. Together, these records give supplement manufacturers a basis for reviewing the raw materials and the powder they receive.
U.S. Launch Focuses on Capsules and Tablets
Givaudan is offering Novaberin™ to U.S. customers as a powder for capsules and tablets. The study used two 250 mg servings of the blend per day, a practical reference point for developers estimating capsule fill weight or tablet size. In a multi-ingredient product, the amount of powder a dosage unit can accommodate also depends on the other ingredients and excipients in the formula. Givaudan introduced Novaberin™ at booth 3264 as part of its broader nutrition portfolio, positioning the ingredient for supplement projects in the metabolic wellness category.


